As filed with the Securities and Exchange Commission on May 7, 2002.
Registration No. 333-86674
==============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
---------------
CENDANT CORPORATION
(Exact name of Registrant as specified in its charter)
DELAWARE 06-0918165
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification Number)
9 West 57th Street
New York, NY 10019
(212) 413-1800
Fax: (212) 413-1922
(Address, Including Zip Code, and Telephone Number,
Including Area Code, of each Registrant's Principal Executive Offices)
James E. Buckman, Esq.
Vice Chairman and General Counsel
Cendant Corporation
9 West 57th Street
New York, NY 10019
(212) 413-1800
Fax: (212) 413-1923
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
Copy to:
Vincent J. Pisano, Esq. Eric J. Bock, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP Executive Vice President, Law and Secretary
4 Times Square Cendant Corporation
New York, NY 10036 9 West 57th Street
(212) 735-3000 New York, NY 10019
Fax: (212) 735-2000 (212) 413-1800
Fax: (212) 413-1922
Approximate date of commencement of proposed sale to the public: From time
to time after the effective date of this registration statement.
If the only securities being registered on this Form are being
offered pursuant to dividend or interest reinvestment plans, check the
following box. |_|
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following box. |X|
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. |_|
If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. |_|
If delivery of the prospectus is expected to be made pursuant to
Rule 434, please check the following box: |_|
The Registrant hereby amends this registration statement on such
date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that
this registration statement shall thereafter become effective in accordance
with Section 8(a) of the Securities Act of 1933 or until the registration
statement shall become effective on such date as the Commission, acting
pursuant to said Section 8(a), may determine.
==============================================================================
Subject to completion, dated May 7, 2002
PROSPECTUS
[FLAG]
The information in this prospectus is not complete and
may be changed. The selling securityholders may not sell these securities
until the registration statement filed with the Securities and Exchange
Commission is effective. This prospectus is not an offer to sell these
securities and we are not soliciting offers to buy these securities in any
state where the offer or sale is not permitted.
{FLAG END]
CENDANT CORPORATION
9,920,000 Shares
CD Common Stock
-----------
This prospectus relates to the sale by from time to time on
behalf of a selling stockholder of Cendant Corporation, including its
transferees, donees, pledgees or successors, of up to 9,920,000 shares of
CD common stock, par value $0.01 per share, of Cendant Corporation.
The shares of CD common stock are being registered to permit the
resale, on behalf of the selling stockholder, of shares of CD common stock
from time to time in the public market. These shares may be sold through
ordinary brokerage transactions or through any other means described in
this prospectus under "Plan of Distribution." We cannot assure you that all
or any portion of the shares of CD common stock offered under this
prospectus will be resold.
For a description of our CD common stock, please refer to the
description of common stock in "Summary Comparison of Terms of Existing
Common Stock with Terms of CD Common Stock and Move.com Common Stock" in
our Proxy Statement, dated February 10, 2000 (filed February 11, 2000),
which is incorporated herein by reference.
Our CD common stock is listed on the New York Stock Exchange under
the symbol "CD." On May 6, 2002, the last reported sale price of our CD
common stock was $17.82.
Investing in shares of our CD common stock involves risks. See
"Risk Factors" beginning on page 10 of this prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these securities or
determined if this prospectus or the accompanying prospectus supplement is
truthful or complete. Any representation to the contrary is a criminal
offense.
The date of this prospectus is , 2002.
No dealer, salesperson or other person has been authorized to give
any information or to make any representations other than those contained
or incorporated by reference in this prospectus in connection with the
offer contained in this prospectus and, if given or made, such information
or representations must not be relied upon as having been authorized by
Cendant. Neither the delivery of this prospectus nor any sale made
hereunder shall under any circumstances create an implication that there
has been no change in the affairs of Cendant since the date hereof. This
prospectus does not constitute an offer to sell or a solicitation of an
offer to buy securities other than those specifically offered hereby or of
any securities offered hereby in any jurisdiction where, or to any person
to whom, it is unlawful to make such offer or solicitation. The information
contained in this prospectus speaks only as of the date of this prospectus
unless the information specifically indicates that another date applies.
TABLE OF CONTENTS
About this Prospectus.........................................................4
Cautionary Statement Concerning Forward-Looking Statements....................4
Incorporation of Certain Documents by Reference...............................7
Cendant.......................................................................8
Risk Factors.................................................................10
Use of Proceeds..............................................................12
Dividend Policy..............................................................12
Description of CD Common Stock...............................................13
Selling Stockholder..........................................................16
Plan of Distribution.........................................................18
Legal Matters................................................................22
Experts......................................................................22
Where You Can Find More Information..........................................22
ABOUT THIS PROSPECTUS
This prospectus relates to the sale by a selling stockholder of up
to 9,920,000 shares of our CD common stock. The selling stockholder may
sell the securities described in this prospectus in one or more offerings.
This prospectus provides you with a general description of the securities
the selling stockholder may offer. Each time the selling stockholder sells
shares of our CD common stock, a prospectus supplement will be provided
that will contain specific information about the terms of that offering to
the extent required. You should read this prospectus and any accompanying
prospectus supplement together with the additional information contained
under the headings "Incorporation of Certain Documents by Reference" and
"Where You Can More Information." All references to "we," "us," "our," or
"Cendant" in this prospectus are to Cendant Corporation.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Forward-looking statements in this prospectus about Cendant are
subject to known and unknown risks, uncertainties and other factors which
may cause our actual results, performance or achievements to be materially
different from any future results, performance or achievements expressed or
implied by such forward-looking statements. These forward-looking
statements were based on various factors and were derived utilizing
numerous important assumptions and other important factors that could cause
actual results to differ materially from those in the forward-looking
statements. Forward-looking statements include the information concerning
our future financial performance, business strategy, projected plans and
objectives.
Statements preceded by, followed by or that otherwise include the
words "believes", "expects", "anticipates", "intends", "project",
"estimates", "plans", "may increase", "may fluctuate" and similar
expressions or future or conditional verbs such as "will", "should",
"would", "may" and "could" are generally forward-looking in nature and not
historical facts. You should understand that the following important
factors and assumptions could affect our future results and could cause
actual results to differ materially from those expressed in such
forward-looking statements:
o the impacts of the September 11, 2001 terrorist attacks on
New York City and Washington D.C. on the travel industry in
general, and our travel businesses in particular, are not
fully known at this time, but are expected to include
negative impacts on financial results due to reduced demand
for travel in the near term; other attacks, acts of war, or
measures taken by governments in response thereto may
negatively affect the travel industry, our financial
results and could also result in a disruption in our
business;
o the effect of economic conditions and interest rate changes
on the economy on a national, regional or international
basis and the impact thereof on our businesses;
o the effects of a decline in travel, due to political
instability, adverse economic conditions or otherwise, on
our travel related business;
o the effects of changes in current interest rates,
particularly on our real estate franchise and mortgage
businesses;
o the resolution or outcome of our unresolved pending
litigation relating to the previously announced accounting
irregularities and other related litigation;
o our ability to develop and implement operational,
technological and financial systems to manage growing
operations and to achieve enhanced earnings or effect cost
savings;
o competition in our existing and potential future lines of
business and the financial resources of, and products
available to, competitors;
o failure to reduce quickly our substantial technology costs
in response to a reduction in revenue, particularly in our
computer reservations and global distribution systems
businesses;
o our failure to provide fully integrated disaster recovery
technology solutions in the event of a disaster;
o our ability to integrate and operate successfully acquired
and merged businesses and risks associated with such
businesses, including the acquisitions of Galileo
International Inc. and Cheap Tickets, Inc., the
compatibility of the operating systems of the combining
companies, and the degree to which our existing
administrative and back-office functions and costs and
those of the acquired companies are complementary or
redundant;
o our ability to obtain financing on acceptable terms to
finance our growth strategy and to operate within the
limitations imposed by financing arrangements and to
maintain our credit ratings;
o competitive and pricing pressures in the vacation ownership
and travel industries, including the car rental industry;
o changes in the vehicle manufacturer repurchase arrangements
in our Avis car rental business in the event that used
vehicle values decrease;
o and changes in laws and regulations, including changes in
accounting standards and privacy policy regulation.
Other factors and assumptions not identified above were also
involved in the derivation of these forward-looking statements, and the
failure of such other assumptions to be realized as well as other factors
may also cause actual results to differ materially from those projected.
Most of these factors are difficult to predict accurately and are generally
beyond our control.
You should consider the areas of risk described above in
connection with any forward-looking statements that may be made by us and
our businesses generally. Except for our ongoing obligations to disclose
material information under the federal securities laws, we undertake no
obligation to release publicly any revisions to forward-looking statements,
to report events or to report the occurrence of unanticipated events unless
required by law. You are advised, however, to consult any additional
disclosures we make in our Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, and Current Reports on Form 8-K to the Securities and Exchange
Commission (the "Commission"). See "Where You Can Find More Information."
Also note that we provide a cautionary discussion of risks and
uncertainties under "Risk Factors" on page 10 of this prospectus. These are
factors that we think could cause our actual results to differ materially
from expected results. Other factors besides those listed here could also
adversely affect us. For any forward-looking statements contained in any
document, we claim the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform Act of
1995.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The Commission allows us to "incorporate by reference" the
information we file with the Commission, which means that we can disclose
important information to you by referring to another document filed
separately with the Commission. The information that Cendant files after
the date of this prospectus with the Commission will automatically update
and supersede this information. Cendant incorporates by reference into this
prospectus the documents listed below and any future filings made with the
Commission under sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), until all of the
shares of CD common stock offered by this prospectus are sold.
o Annual Report on Form 10-K for the year ended December 31,
2001, filed on April 1, 2002;
o Current Reports on Form 8-K dated October 15, 2001, April 1,
2002 and, April 17, 2002 (filed on April 18, 2002), May 1,
2002 and May 3, 2002; and
o The description of Cendant's CD common stock contained in
the Proxy Statement dated February 10, 2000, filed on
February 11, 2000.
All documents filed by Cendant with the Commission from the date
of this prospectus to the end of the offering of the shares of CD common
stock shall also be deemed to be incorporated herein by reference.
Any statement contained in a document incorporated or considered
to be incorporated by reference in this registration statement shall be
considered to be modified or superseded for purposes of this prospectus to
the extent that a statement contained in this registration statement or in
any subsequently filed document that is or is considered to be incorporated
by reference modifies or supersedes such statement. Any statement that is
modified or superseded shall not, except as so modified or superseded,
constitute a part of this prospectus.
You may request a copy of any of the documents which are
incorporated by reference in this prospectus, other than exhibits which are
not specifically incorporated by reference into such documents and our
Certificate of Incorporation and By-Laws, at no cost, by writing or
telephoning Cendant at the following:
Investor Relations
Cendant Corporation
9 West 57th Street
New York, NY 10019
Telephone: (212) 413-1800
CENDANT
We are one of the foremost providers of travel and real estate
services in the world. Our businesses provide a wide range of consumer and
business services and are intended to complement one another and create
cross-marketing opportunities both within and among our following five
business segments:
o Our Real Estate Services segment franchises the real estate
brokerage businesses of the CENTURY 21(R), Coldwell
Banker(R), Coldwell Banker Commercial(R) and ERA(R) brands;
provides home buyers with mortgages through Cendant Mortgage
Corporation and assists in employee relocations through
Cendant Mobility Services Corporation.
o Our Hospitality segment operates the Days Inn(R), Ramada(R)
(in the United States), Super 8 Motel(R), Howard Johnson(R),
Wingate Inn(R), Knights Inn(R), Travelodge(R) (in North
America), Villager Lodge(R)/Village Premier(R)/Hearthside by
Villager and AmeriHost Inn(R) lodging franchise systems,
facilitates the sale and exchange of vacation ownership
intervals through Resort Condominiums International, LLC,
Fairfield Resorts, Inc. and Equivest Finance, Inc. and
markets vacation rental properties in Europe through Holiday
Cottages and Cuendet.
o Our Vehicle Services segment operates and franchises our
Avis(R) car rental business; provides fleet management and
fuel card services to corporate clients and government
agencies through PHH Arval and Wright Express and operates
parking facilities in the United Kingdom through our
National Car Parks subsidiary.
o Our Travel Distribution segment provides global distribution
and computer reservation services to airlines, hotels, car
rental companies and other travel suppliers and provides our
travel agent customers the ability to electronically access
airline schedule and fare information, book reservations,
and issue tickets through Galileo International, provides
travel services through our Cendant Travel and Cheap Tickets
travel agency businesses, and provides reservations
processing, connectivity and information management services
through WizCom.
o Our Financial Services segment provides enhancement packages
to financial institutions through FISI*Madison LLC, provides
insurance-based products to consumers through Benefit
Consultants, Inc. and Long Term Preferred Care, Inc.,
provides loyalty solutions to businesses through Cims Ltd.,
operates and franchises tax preparation services through
Jackson Hewitt Inc. and provides a variety of membership
programs offering discounted products and services to
consumers through our relationship with Trilegiant Corporation.
Our principal executive offices are located at 9 West 57th Street,
New York, New York 10019. Our telephone number is (212) 413-1800. Our web
site is www.cendant.com. The information contained on our web site is not
incorporated by reference in this prospectus.
***
We seek organic growth augmented by the acquisition and
integration of complementary businesses. As a result, we are currently
engaged in a number of preliminary discussions concerning possible
acquisitions and intend to continually explore and conduct discussions with
regard to other acquisitions and other strategic corporate transactions.
The purchase price for any possible transaction may be paid in cash, stock,
other securities, borrowings, or a combination thereof. Prior to
consummating any transaction, we will need to, among other things, initiate
and satisfactorily complete our due diligence investigations; negotiate the
financial and other terms (including price) and conditions of such
transactions; obtain appropriate board of directors, regulatory and
shareholder or other necessary consents and approvals; and, if necessary,
secure financing. No assurance can be given with respect to the timing,
likelihood or business effect of any possible transaction. In the past, we
have been involved in both relatively small and significant acquisitions.
In addition, we continually review and evaluate our portfolio of
existing businesses to determine if they continue to meet our business
objectives. As part of our ongoing evaluation of such businesses, we intend
from time to time to explore and conduct discussions with regard to joint
ventures, divestitures and related corporate transactions. However, we can
give no assurance with respect to the magnitude, timing, likelihood or
financial or business effect of any possible transaction. We also cannot
predict whether any divestitures or other transactions will be consummated
or, if consummated, will result in a financial or other benefit to us. We
intend to use a portion of the proceeds from any such dispositions and cash
from operations to retire indebtedness, make acquisitions and for other
general corporate purposes.
RISK FACTORS
You should carefully consider the following risk factor and other
information contained or incorporated by reference in this prospectus and
any accompanying prospectus supplement before deciding to purchase any
shares of CD common stock.
We have had accounting irregularities and related litigation and
governmental investigations.
Cendant was created in December 1997, through the merger of HFS
Incorporated into CUC International, Inc. with CUC surviving and changing
its name to Cendant Corporation. On April 15, 1998, Cendant announced that
in the course of transferring responsibility for Cendant's accounting
functions from Cendant personnel associated with CUC prior to the merger to
Cendant personnel associated with HFS before the merger and preparing for
the report of first quarter 1998 financial results, Cendant discovered
accounting irregularities in some of the CUC business units. As a result,
Cendant, together with its counsel and assisted by auditors, immediately
began an intensive investigation. As a result of the findings of the
investigations, Cendant restated its previously reported financial results
for 1997, 1996 and 1995 and the six months ended June 30, 1998.
Following the April 15, 1998 announcement of the discovery of
accounting irregularities in the former business units of CUC,
approximately 70 lawsuits claiming to be class actions, three lawsuits
claiming to be brought derivatively on Cendant's behalf and several
individual lawsuits and arbitration proceedings were commenced in various
courts and other forums against Cendant and other defendants by or on
behalf of persons claiming to be stockholders of Cendant and persons
claiming to have purchased or otherwise acquired securities or options
issued by CUC or Cendant between May 1995 and August 1998.
The SEC and the United States Attorney for the District of New
Jersey have conducted investigations relating to the matters referenced
above. As a result of the findings from our internal investigations, we
made all adjustments considered necessary by Cendant, which are reflected
in our previously filed restated financial statements for the years ended
December 31, 1997, 1996 and 1995 and for the six months ended June 30,
1998. On June 14, 2000, pursuant to an offer of settlement made by Cendant,
the SEC issued an Order Instituting Public Administrative Proceedings
Pursuant to Section 21C of the Securities Exchange Act of 1934, Making
Findings and Imposing a Cease and Desist Order. In such Order, the SEC
found that we had violated certain financial reporting provisions of the
Exchange Act and ordered us to cease and desist from committing any future
violations of such provisions. No financial penalties were imposed against
us.
On December 7, 1999, we announced that we had reached a
preliminary agreement to settle the principal securities class action
pending against Cendant in the U.S. District Court in Newark, New Jersey,
brought on behalf of purchasers of all Cendant and CUC publicly traded
securities, other than PRIDES, between May 1995 and August 1998. A portion
of the PRIDES litigation had previously been settled through the issuance
of rights. Under the settlement agreement, we would pay the class members
approximately $2.85 billion in cash and 50% of any recovery we may obtain
in connection with claims we have asserted against CUC's former public
auditor. The definitive settlement document was approved by the U.S.
District Court by order dated August 14, 2000. Certain parties in the class
action appealed various aspects of the District Court's orders approving
the settlement. In August 2001, the U.S. Court of Appeals for the Third
Circuit affirmed the judgment of the District Court approving the
settlement (but remanded the case back to the District Court for further
proceedings concerning an award of fees to the class attorneys, a matter in
which we have no interest). One party in the class action has petitioned
the U.S. Supreme Court to hear her challenge to the plan of allocation of
the settlement funds among the class members. On March 18, 2002, the U.S.
Supreme Court declined to review the matter. The settlement agreement
required us to post collateral in the form of credit facilities and/or
surety bonds by November 13, 2000, which we have done. In light of the
Supreme Court's action on March 18, 2002, the settlement is required to be
fully funded by July 16, 2002.
The settlement does not encompass all litigations asserting claims
against us associated with the accounting irregularities. We do not believe
that it is feasible to predict or determine the final outcome or resolution
of these unresolved proceedings. An adverse outcome from such unresolved
proceedings could be material with respect to earnings in any given
reporting period. However, we do not believe that the impact of such
unresolved proceedings should result in a material liability to us in
relation to our financial position or liquidity.
USE OF PROCEEDS
Pursuant to the terms of the Stock Purchase Agreement described
under the sections of this prospectus entitled "Selling Stockholder" and
"Plan of Distribution," we will be entitled to receive the proceeds
from the sales by the selling stockholder of the shares of our CD common
stock if, and to the extent, the aggregate proceeds from the sale of all of
the shares of CD common stock sold pursuant to this prospectus exceed $186
million. If we receive any such proceeds, they will be used for general
corporate purposes. Unless these circumstances occur, all proceeds from the
sale of shares of our CD common stock will go to the selling stockholder
who offers and sells its shares.
DIVIDEND POLICY
We have never paid a cash dividend on our capital stock. We do not
anticipate paying cash dividends on our capital stock in the foreseeable
future and intend to retain all earnings to finance the operations and
expansion of our business and to reduce debt. The payment of cash dividends
in the future will depend on our earnings, financial condition and capital
needs and on other factors deemed relevant by our board of directors at
that time. For further information regarding our payment of dividends, see
"Summary Comparison of Terms of Existing Common Stock with Terms of CD
Common Stock and Move.com Common Stock" in our Proxy Statement, dated
February 10, 2000, which is incorporated herein by reference.
DESCRIPTION OF CD COMMON STOCK
The following description of Cendant's CD common stock does not
purport to be complete and is subject to, and qualified in its entirety by
reference to, the more complete descriptions thereof set forth in our
Amended and Restated Certificate of Incorporation (the "Certificate") and
Amended and Restated By-Laws (the "By-Laws").
We are authorized to issue up to 2,000,000,000 shares of CD common
stock, par value $.01 per share. As of March 15, 2002, there were
982,020,341 shares of CD common stock outstanding.
General
In March 2000, our outstanding common stock was reclassified as CD
common stock, and we created a series of common stock designated as
Move.com common stock. The Move.com common stock was designed to track the
value of our Move.com Group, and the CD common stock represents our
interests in the remainder of our business and our interest in Move.com
Group. No shares of Move.com common stock are outstanding. For a
description of the terms of our CD common stock, see "Summary Comparison of
Terms of Existing Common Stock with Terms of CD Common Stock and Move.com
Common Stock" in the Proxy Statement dated February 10, 2000, which is
incorporated by reference herein.
Subject to the rights of the holders of any shares of our
preferred stock which may at the time be outstanding, holders of CD common
stock are entitled to such dividends as the Board of Directors may declare
out of funds legally available therefor. The holders of CD common stock
will possess exclusive voting rights in us, except to the extent the Board
of Directors specifies voting power with respect to any preferred stock
issued. Except as hereinafter described, holders of CD common stock are
entitled to one vote for each share of CD common stock, but will not have
any right to cumulate votes in the election of directors. In the event of
liquidation, dissolution or winding up of Cendant, the holders of CD common
stock are entitled to receive, after payment of all of our debts and
liabilities and of all sums to which holders of any preferred stock may be
entitled, the distribution of any remaining assets of Cendant. Holders of
the CD common stock will not be entitled to preemptive rights with respect
to any shares which may be issued. All outstanding shares of CD common
stock are fully paid and non-assessable. The CD common stock is listed on
the New York Stock Exchange under the symbol "CD."
Certain Provisions
The provisions of our Certificate and By-Laws which are summarized
below may be deemed to have an anti-takeover effect and may delay, defer or
prevent a tender offer or takeover attempt that a stockholder might
consider in such stockholder's best interest, including those attempts that
might result in a premium over the market price for the shares held by
stockholders.
Classified Board
Our Board of Directors is divided into three classes that are
elected for staggered three-year terms. A director may be removed by the
stockholders without cause only by the affirmative vote of the holders,
voting as a single class, of 80% or more of the total number of votes
entitled to be cast by all holders of our voting stock, which shall include
all capital stock of Cendant which by its terms may vote on all matters
submitted to stockholders of Cendant generally.
Committees of the Board of Directors
Pursuant to the Certificate, the Board of Directors' authority to
designate committees shall be subject to the provisions of the By-Laws. The
Board of Directors may designate one or more directors as alternate members
of any committee to fill any vacancy on the committee and to fill a vacant
chairmanship of a committee occurring as a result of a member or chairman
leaving the committee, whether through death, resignation, removal or
otherwise. Pursuant to the By-Laws, the Board of Directors shall have the
following committees:
Executive Committee. An Executive Committee consisting of not less
than three directors elected by a majority vote of the Board of Directors.
Compensation Committee. A Compensation Committee consisting of not
less than three directors elected by a majority vote of the Board of
Directors.
Audit Committee. An Audit Committee consisting of not less than
four directors elected by a majority vote of the Board of Directors.
Newly Created Directorships and Vacancies
Newly created directorships resulting from any increase in the
number of directors and any vacancies on the Board of Directors resulting
from death, resignation, disqualification, removal or other cause shall be
filled solely by the affirmative vote of a majority of the remaining
directors then in office, even though less than a quorum of the Board of
Directors. Any directors elected in accordance with the preceding sentence
shall hold office for the remainder of the full term of the class of
directors in which the new directorship was created or the vacancy occurred
and until such director's successor shall have been elected and qualified.
No decrease in the number of directors constituting the Board of Directors
shall shorten the term of any incumbent director.
Special Meetings of Stockholders
A special meeting of stockholders may be called only by the
Chairman of the Board of Directors, the President or the Board of Directors
pursuant to a resolution approved by a majority of the entire Board of
Directors.
Quorum at Stockholder Meetings
The holders of one-third of the shares entitled to vote at any
meeting of the stockholders, present in person or by proxy, shall
constitute a quorum at all stockholder meetings.
Stockholder Action By Written Consent
Stockholder action by written consent in lieu of a meeting is
prohibited under the Certificate. As a result, stockholder action can be
taken only at an annual or special meeting of stockholders. This prevents
the holders of a majority of the outstanding voting stock of Cendant from
using the written consent procedure to take stockholder action without
giving all the stockholders of Cendant entitled to vote on a proposed
action the opportunity to participate in determining the proposed action.
Advance Notice of Stockholder-Proposed Business at Annual Meetings
Our By-Laws provide that for business to be properly brought
before an annual meeting by a stockholder, the stockholder must have given
timely notice thereof in writing to the Secretary of Cendant. To be timely,
a stockholder's notice must be delivered to or mailed and received at the
principal executive offices of Cendant, not less than 60 days nor more than
90 days prior to the meeting; provided, however, that in the event that
less than 70 days' notice or prior public disclosure of the date of the
meeting is given or made to stockholders, notice by the stockholder to be
timely must be so received not later than the close of business on the
tenth day following the date on which such notice of the date of the annual
meeting was mailed or such public disclosure was made. A stockholder's
notice to the Secretary must set forth as to each matter the stockholder
proposes to bring before the annual meeting: (i) a brief description of the
business desired to be brought before the annual meeting, (ii) the name and
address, as they appear on Cendant's books, of the stockholder proposing
such business, (iii) the class and number of shares of Cendant which are
beneficially owned by the stockholder, and (iv) any material interest of
the stockholder in such business.
In addition, the By-Laws provide that for a stockholder to
properly nominate a director at a meeting of stockholders, the stockholder
must have given timely notice thereof in writing to the Secretary of
Cendant. To be timely, a stockholder's notice must be delivered to or
mailed and received at the principal executive offices of Cendant (i) in
the case of an annual meeting, at least 90 days prior to the first
anniversary of the date of the last annual meeting of Cendant stockholders
and (ii) with respect to a special meeting of stockholders, the close of
business on the 10th day following the date on which notice of such meeting
is first given to stockholders. Such stockholder's notice to the Secretary
must set forth: (i) the name and address of the stockholder who intends to
make the nomination and of the person or persons to be nominated, (ii) a
representation that the stockholder is the holder of record of common stock
and intends to appear in person or by proxy at the meeting to nominate each
such nominee, (iii) a description of all arrangements between such
stockholder and each nominee, (iv) such other information with respect to
each nominee as would be required to be included in a proxy statement filed
pursuant to the proxy rules of the Commission, and (v) the consent of each
nominee to serve as director of the Company if so elected.
Fair Price Provisions
Under the Delaware General Corporation Law and the Certificate, an
agreement of merger, sale, lease or exchange of all or substantially all of
Cendant's assets must be approved by the Board of Directors and adopted by
the holders of a majority of the outstanding shares of stock entitled to
vote thereon. However, the Certificate includes what generally is referred
to as a "fair price provision," which requires the affirmative vote of the
holders of at least 80% of the outstanding shares of capital stock entitled
to vote generally in the election of Cendant's directors, voting together
as a single class, to approve certain business combination transactions
(including certain mergers, recapitalization and the issuance or transfer
of securities of Cendant or a subsidiary having an aggregate fair market
value of $10 million or more) involving Cendant or a subsidiary and an
owner or any affiliate of an owner of 5% or more of the outstanding shares
of capital stock entitled to vote, unless either (i) such business
combination is approved by a majority of disinterested directors, or (ii)
the shareholders receive a "fair price" for their securities and certain
other procedural requirements are met. The Certificate provides that this
provision may not be repealed or amended in any respect except by the
affirmative vote of the holders of not less than 80% of the outstanding
shares of capital stock entitled to vote generally in the election of
directors.
SELLING STOCKHOLDER
Pursuant to the Registration Rights Agreement (defined below), we
are registering shares of our CD common stock to permit the selling
stockholder to offer these shares of CD common stock for resale from time
to time. The shares of CD common stock were issued in connection with the
obligation of Cendant Real Estate Holdings Inc. as purchaser under the
stock purchase agreement, dated as of April 17, 2002 (the "Stock Purchase
Agreement"), by and among Apollo Investment Fund III, L.P., Apollo Overseas
Partners III, L.P. and Apollo (UK) Partners III, L.P., as original sponsors
(the "Original Sponsors"), AP RES LLC, as sponsor (the "Sponsor"), Cendant
Corporation and Cendant Real Estate Holdings Inc., as purchaser (the
"Purchaser"), to issue shares of CD common stock , that were contributed to
the Purchaser, to the Sponsor. The selling stockholder may from time to
time offer and sell pursuant to this prospectus any or all of the shares of
CD common stock listed below. When we refer to the "selling stockholder" in
this prospectus, we mean the person listed in the table below, as well as
the pledgees, donees, assignees, transferees, successors and others who
later hold any of the selling stockholder's interests. The following
description and the description under the section of this prospectus
entitled "Plan of Distribution" are summaries of the material provisions of
the Registration Rights Agreement and the Stock Purchase Agreement which
are filed as exhibits to the registration statement of which this
prospectus forms a part.
Prior to entering into the Stock Purchase Agreement, the Sponsor
was the beneficial and record owner of 6,924,860.99 shares (the "Sponsor
Shares") of common stock, par value $0.01 per share, of NRT Incorporated
("NRT"), which represent all of the outstanding shares of common stock of
NRT. The Original Sponsors contributed the Sponsor Shares to the Sponsor,
which is wholly owned by the Original Sponsors. On December 5, 2000, we,
the Original Sponsors and NRT entered into a letter agreement (the "Option
Agreement"), pursuant to which the Original Sponsors granted us the right
and option (the "Option") to purchase all of the Sponsor Shares (which
Option is binding on the Sponsor) for $20 million. Pursuant to the Option
Agreement, NRT (or Cendant on NRT's behalf) had the obligation to pay
$166 million to the Original Sponsors or their designee on the earlier of
the date of the exercise of the Option or August 11, 2002. Pursuant to the
Stock Purchase Agreement, the Purchaser had the obligation to pay $186
million to the Original Sponsors or their designee, which amount represents
$20 million in payment for the Sponsor Shares and $166 million that NRT (or
Cendant on NRT's behalf) owed to the Original Sponsors under the Option
Agreement.
On April 17, 2002, we, the Sponsor and the Purchaser entered into
the Stock Purchase Agreement to provide for the acquisition of the Sponsor
Shares by the Purchaser in exchange for shares of CD common stock. The
terms and provisions of the Stock Purchase Agreement supercede and replace
the obligations of Cendant and NRT under the Option Agreement and the
Amended and Restated Stockholders Agreement, dated as of September 30, 1999
(the "Stockholders Agreement"), by and among NRT, Apollo Management, L.P.,
the Original Sponsors and Cendant. Pursuant to the Stockholders Agreement,
the Original Sponsors had certain rights with respect to the governance of
NRT, including the right to representation on NRT's board of directors and
approval rights regarding certain transactions. In connection with the
Stock Purchase Agreement, we and the Sponsor entered into a registration
rights agreement, dated as of April 17, 2002, in connection with the shares
of CD common stock issuable pursuant to the Stock Purchase Agreement (the
"Registration Rights Agreement").
Pursuant to the Registration Rights Agreement, we have agreed to
pay all expenses incurred in connection with the registration of the shares
of the CD common stock owned by the selling stockholder covered by this
prospectus, other than any other out-of-pocket expenses of the selling
stockholder.
The table below sets forth the name of the selling stockholder,
the number and percentage of shares of CD common stock that the selling
stockholder beneficially owns prior to this offering, and the number of
shares of CD common stock that the selling stockholder may offer pursuant
to this prospectus. Unless set forth in this prospectus, to our knowledge,
the selling stockholder does not, or within the past three years has not
had, any material relationship with us or any of our predecessors or
affiliates or beneficially owns or owned in excess of 1% of our outstanding
CD common stock.
Since the date on which the selling stockholder provided this
information, the selling stockholder may have sold, transferred or
otherwise disposed of all or a portion of its shares of CD common stock in
a transaction or series of transactions exempt from the registration
requirements of the Securities Act. Information concerning the selling
stockholder may change from time to time and any changed information will
be set forth in supplements to this prospectus to the extent required.
The selling stockholder may from time to time offer and sell any
or all of the shares of CD common stock under this prospectus. We do not
anticipate that the selling stockholder will beneficially own any shares of
CD common stock after this offering.
Number of Shares Percentage of
of CD Common Stock Shares of CD Number of shares of
Beneficially Owned Common Stock CD Common Stock
Prior to the Outstanding Prior covered by this
Name of Selling Stockholder Offering(1) to the Offering(2) Prospectus
----------------------------------------------------------------
AP RES LLC......................... 9,920,000 * 9,920,000
- -----------
* Less than one percent (1%).
(1) Beneficial ownership is determined in accordance with the rules and
regulations of the Commission and generally includes (1) any securities
that are or will become exercisable within the next 60 days and (2)
consideration of voting or investment power with respect to the securities
at issue.
(2) Calculated based on 982,020,341 shares of CD common stock outstanding
as of March 15, 2002 and on each selling stockholder's beneficial ownership
of shares of our CD common stock as of May 6, 2002.
PLAN OF DISTRIBUTION
This prospectus, including any amendment or supplement, may be
used in connection with sales of up to 9,920,000 shares of our CD common
stock. On April 17, 2002, to satisfy the Purchaser's obligation under the
Stock Purchase Agreement, we issued to the Sponsor 9,920,000 shares of our
CD common stock, representing $186 million divided by the last reported
sale price of our CD common stock on April 16, 2002 of $18.75. Pursuant to
the terms of the Stock Purchase Agreement, these shares were placed in a
brokerage account with Credit Suisse First Boston that was opened by the
Sponsor and provides the Purchaser with the sole ability, in its
discretion, to sell, or cause to be sold, the shares of CD common stock
placed in such account. The Purchaser is obligated to cause the sale of the
shares of CD common stock on behalf of the Sponsor from time to time and is
required to use its reasonable efforts to cause the sale of all of the
shares of CD common stock placed into the brokerage account to be completed
no later than the later of August 11, 2002 or 30 days following the
effectiveness date of this registration statement.
Upon the settlement of each sale, the broker is required to remit
the cash proceeds from such sale, net of all underwriters', sale or
brokers' commissions and discounts incurred in connection with such sale to
the Sponsor up to an aggregate of $186 million. If the aggregate proceeds
from the sale of all of the shares of CD common stock exceed $186 million,
the broker is required to pay to Cendant any remaining amounts in excess of
$186 million. If the aggregate proceeds from the sale of all of the sales
of CD common stock are less than $186 million, the Purchaser will be
required to pay the Sponsor the difference between $186 million and the
aggregate proceeds (such amount, the "Adjustment Amount"). The Adjustment
Amount will be payable, at the Purchaser's option, in cash or additional
shares of CD common stock. Such shares, if any, will be placed in the
brokerage account, and the Purchaser shall cause the additional shares of
CD common stock to be sold on behalf of the Sponsor as soon as practicable.
If the aggregate proceeds from the sale of the additional shares exceeds
the Adjustment Amount, Cendant will be entitled to receive any remaining
amounts in excess of the Adjustment Amount. If the aggregate proceeds from
the sale of the additional shares are less than the Adjustment Amount, the
Purchaser will be required to pay the Sponsor such difference or continue
to deposit additional shares of CD common stock into the brokerage account
until the Sponsor shall have received an aggregate of $186 million.
Notwithstanding the foregoing, if by August 11, 2002, the Sponsor
has not received $186 million, then the Purchaser and Cendant will be
obligated to pay to the Sponsor, no later than August 11, 2002, cash equal
to the difference between $186 million and the amount received by Sponsor.
If the Purchaser is in default of this obligation after August 16, 2002,
the Sponsor will have the sole ability, in its discretion, to sell or cause
to be sold at prevailing market prices any shares of CD common stock still
remaining in the brokerage account.
The transfer of the shares of CD common stock covered by this
prospectus by the selling stockholder is subject to certain restrictions
set forth in the Stock Purchase Agreement. We are registering the shares of
CD common stock covered by this prospectus to permit the resale of these
shares from time to time after the date of this prospectus. Pursuant to the
Registration Rights Agreement, we have agreed, among other things, to pay
all expenses incurred in connection with the registration of the shares of
CD common stock covered by this prospectus, other than any other
out-of-pocket expenses of the selling stockholder.
All or a portion of the shares of CD common stock beneficially
owned by the selling stockholder and offered hereby will be sold from time
to time:
o directly; or
o through underwriters, broker-dealers or agents, which may
include Credit Suisse First Boston Corporation, including as
set forth in the Stock Purchase Agreement, who may receive
compensation in the form of discounts, commissions or
concessions from the selling stockholder and/or from the
purchasers of the shares of CD common stock for whom they may
act as agent.
The shares of CD common stock may be sold from time to time in one
or more transactions at:
o fixed prices, which may be changed;
o prevailing market prices at the time of sale;
o varying prices determined at the time of sale; or
o negotiated prices.
Pursuant to the Stock Purchase Agreement, for a certain period of
time, the prices and manner of sale of the shares of CD common stock will
be determined solely in our discretion.
The sales described in the preceding paragraph may be effected in
transactions:
o on the New York Stock Exchange or any exchange on which our
shares of CD common stock may then be listed;
o in the over-the counter market;
o in transactions otherwise than on such exchanges or services
or in the over-the-counter market; or
o through the writing of options.
These transactions may include block transactions or crosses.
Crosses are transactions in which the same broker acts as an agent on both
sides of the trade.
In connection with sales of the shares of CD common stock or
otherwise, the selling stockholder may enter into hedging transactions with
broker-dealers. These broker-dealers may in turn engage in short sales of
the shares of CD common stock in the course of hedging their positions. The
selling stockholder may also sell the shares of CD common stock short and
deliver the shares of CD common stock to close out short positions, or loan
or pledge the shares of CD common stock to broker-dealers that in turn may
sell the shares of CD common stock.
The selling stockholder may not sell any, or may not sell all, of
the shares of CD common stock offered by it pursuant to this prospectus. In
addition, we cannot assure you that the selling stockholder will not
transfer, devise or gift the shares of CD common stock by other means not
described in this prospectus. The Stock Purchase Agreement sets forth
certain restrictions with respect to the transfer of the shares of CD
common stock offered by this prospectus.
The outstanding shares of CD common stock are listed for trading
on the New York Stock Exchange.
Any broker and any broker-dealers, agents or underwriters that
participate with the selling stockholder in the distribution of the shares
of CD common stock may be deemed to be "underwriters" within the meaning of
the Securities Act. In this case, any commissions received by these
broker-dealers, agents or underwriters and any profit on the resale of the
shares of CD common stock purchased by them may be deemed to be
underwriting commissions or discounts under the Securities Act.
The selling stockholder and any broker, broker-dealer or agent
deemed to be an underwriter within the meaning of Section 2(11) of the
Securities Act will be subject to the prospectus delivery requirements of
the Securities Act. At any time a particular offer of the shares of CD
common stock is made, a revised prospectus or prospectus supplement, if
required, will be distributed which discloses:
o the name of the selling stockholder and any participating
underwriters, broker-dealers or agents, which may include
Credit Suisse First Boston Corporation;
o the aggregate amount and type of securities being offered;
o the price at which the securities were sold and other material
terms of the offering;
o any discounts, commissions, concessions or other items
constituting compensation from the selling stockholder and any
discounts, commissions or concessions allowed or reallowed or
paid to dealers; and
o that the participating broker-dealers did not conduct any
investigation to verify the information in this prospectus or
incorporated in this prospectus by reference.
The prospectus supplement or a post-effective amendment will be
filed with the Commission to reflect the disclosure of additional
information with respect to the distribution of the shares of CD common
stock.
We have agreed to indemnify the Sponsor and any of its affiliates,
their respective directors and officers, each other person who participates
as an underwriter in an offering or sale of the shares of CD common stock
and each other person, if any, who controls the Sponsor or any such
underwriter within the meaning of the Securities Act, and the selling
stockholder has agreed to indemnify us, our directors, our officers who
sign the registration statement to which this prospectus relates, each
person, if any, who controls Cendant within the meaning of either Section
15 of the Securities Act or Section 20 of the Exchange Act, each other
person who participates as an underwriter in an offering and sale of the
shares of CD common stock and each other person, if any, who controls the
selling stockholder or any such underwriter within the meaning of the
Securities Act, against specified liabilities arising under the Securities Act.
The selling stockholder and any other person participating in such
distribution will be subject to the Exchange Act. The Exchange Act rules
include, without limitation, Regulation M, which may limit the timing of
purchases and sales of any of the shares of CD common stock by the selling
stockholder and any such other person. In addition, Regulation M of the
Exchange Act may restrict the ability of any person engaged in the
distribution of the shares of CD common stock to engage in market-making
activities with respect to the particular shares of CD common stock being
distributed for a period of up to five business days prior to the
commencement of distribution. This may affect the marketability of the
shares of CD common stock and the ability of any person or entity to engage
in market-making activities with respect to the shares of CD common stock.
We have agreed to use our reasonable efforts to keep the
registration statement of which this prospectus is a part effective until
the date when all of the shares of CD common stock registered under this
registration statement have been sold pursuant to the registration
statement.
Our obligation to keep the registration statement to which this
prospectus relates effective is subject to certain permitted exceptions. In
these cases, we may prohibit offers and sales of the shares of CD common
stock pursuant to the registration statement to which this prospectus
relates. In addition, we may suspend the use of this prospectus if we learn
of any event that causes this prospectus to include an untrue statement of
a material fact required to be stated in the prospectus or necessary to
make the statements in the prospectus not misleading in light of the
circumstances then existing. If this type of event occurs, a prospectus
supplement or post-effective amendment, if required, will be distributed to
the selling stockholder. The selling stockholder has agreed not to trade
shares of CD common stock from the time the selling stockholder receives
notice from us of this type of event until the selling stockholder receives
a prospectus supplement or amendment. These time periods will not exceed an
aggregate of 90 days in any 12-month period.
LEGAL MATTERS
The validity of the shares of CD common stock offered hereby will
be passed upon for us by Eric J. Bock, Esq., Executive Vice President, Law
and Secretary of Cendant. Mr. Bock holds shares of CD common stock and
options to acquire shares of CD common stock..
EXPERTS
The consolidated financial statements of Cendant Corporation and
subsidiaries incorporated in this prospectus by reference from our Annual
Report on Form 10-K for the year ended December 31, 2001 have been audited
by Deloitte & Touche LLP, independent auditors, as stated in their report
(which expresses an unqualified opinion and includes an explanatory
paragraph relating to the modification of accounting for interest income
and impairment of beneficial interests in securitization transactions, the
accounting for derivative instruments and hedging activities and the
revision of certain revenue recognition policies as discussed in Note 1),
which is incorporated herein by reference, and have been so incorporated in
reliance upon the report of such firm given upon their authority as experts
in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
Cendant is subject to the informational requirements of the
Exchange Act, and in accordance therewith files reports, proxy statements
and other information with the Commission. Such reports, proxy statements
and other information can be inspected and copied at prescribed rates at
the public reference facilities maintained by the Commission at Judiciary
Plaza, 450 Fifth Street, N.W., Washington, D.C. 20549, and at the Regional
Office of the Commission located at Northwestern Atrium Center, 500 West
Madison Street, Suite 1400, Chicago, IL 60661. The Commission also
maintains a website that contains reports, proxy and information statements
and other information. Please call the Commission at 1-800-SEC-0330 for
further information on the public reference rooms. The website address is
http://www.sec.gov. In addition, such material can be inspected at the
offices of the New York Stock Exchange, 20 Broad Street, New York, New York
10005.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution
Cendant is paying all of the selling stockholder's expenses
related to this offering. The following table sets forth the approximate
amount of fees and expenses payable by Cendant in connection with this
Registration Statement and the distribution of the shares of CD common
stock registered hereby. All of the amounts shown are estimates except the
Securities and Exchange Commission registration fee.
Securities and Exchange Commission Registration Fee....... $ 17,112
Accounting Fees and Expenses.............................. $ 100,000
Legal Fees and Expenses................................... $ 50,000
Miscellaneous............................................. $ 200,000
---------
Total ........................................... $ 367,112
=========
Item 15. Indemnification of Directors and Officers
Section 102 of the General Corporation Law of the State of
Delaware allows a corporation to eliminate the personal liability of
directors to a corporation or its stockholders for monetary damages for a
breach of a fiduciary duty as a director, except where the director
breached his duty of loyalty, failed to act in good faith, engaged in
intentional misconduct or knowingly violated a law, authorized the payment
of a dividend or approved a stock repurchase or redemption in violation of
Delaware corporate law or obtained an improper personal benefit.
Section 145 of the Delaware General Corporation Law empowers a
Delaware corporation to indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of such corporation)
by reason of the fact that such person is or was a director, officer,
employee or agent of such corporation, or is or was serving at the request
of such corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise. The
indemnity may include expenses (including attorneys' fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by
such person in connection with such action, suit or proceeding, provided
that such person acted in good faith and in a manner such person reasonably
believed to be in or not opposed to the best interests of the corporation
and, with respect to any criminal action or proceeding, had no reasonable
cause to believe such person's conduct was unlawful. A Delaware corporation
may indemnify directors, officers, employees and other agents of such
corporation in an action by or in the right of a corporation under the same
conditions against expenses (including attorney's fees) actually and
reasonably incurred by the person in connection with the defense and
settlement of such action or suit, except that no indemnification is
permitted without judicial approval if the person to be indemnified has
been adjudged to be liable to the corporation. Where a present or former
director or officer of the corporation is successful on the merits or
otherwise in the defense of any action, suit or proceeding referred to
above or in defense of any claim, issue or matter therein, the corporation
must indemnify such person against the expenses (including attorneys' fees)
which he or she actually and reasonably incurred in connection therewith.
Section 174 of the General Corporation Law of the State of
Delaware provides, among other things, that a director who willfully or
negligently approves of an unlawful payment of dividends or an unlawful
stock purchase or redemption, may be held liable for such actions. A
director who was either absent when the unlawful actions were approved or
dissented at the time, may avoid liability by causing his or her dissent to
such actions to be entered into the books containing the minutes of the
meetings of the board of directors at the time such action occurred or
immediately after such absent director receives notice of the unlawful acts.
The Registrant's By-Laws contain provisions that provide for
indemnification of officers and directors and their heirs and distributees
to the full extent permitted by, and in the manner permissible under, the
General Corporation Law of the State of Delaware.
As permitted by Section 102(b)(7) of the General Corporation Law
of the State of Delaware, the Registrant's Amended and Restated Certificate
of Incorporation contains a provision eliminating the personal liability of
a director to the Registrant or its stockholders for monetary damages for
breach of fiduciary duty as a director, subject to some exceptions.
Cendant Corporation maintains, at its expense, a policy of
insurance which insures its directors and officers, subject to exclusions
and deductions as are usual in these kinds of insurance policies, against
specified liabilities which may be incurred in those capacities.
Item 16. Exhibits
The following is a list of all exhibits filed as a part of this
registration statement on Form S-3, including those incorporated in this
registration statement by reference.
Exhibit
Number Description of Exhibits
- ------ -----------------------
3.1 Amended and Restated Certificate of Incorporation of
Cendant Corporation (incorporated by reference to Exhibit
3.1 to Cendant Corporation's Quarterly Report on Form
10-Q/A filed by Cendant Corporation on July 28, 2000 for
the quarterly period ended March 31, 2000).
3.2 Amended and Restated By-Laws of Cendant Corporation
(incorporated by reference to Exhibit 3.2 to Cendant
Corporation's Quarterly Report on Form 10-Q/A filed by
Cendant Corporation on July 28, 2000 for the quarterly
period ended March 31, 2000).
4.1 Form of Stock Certificate (incorporated by reference to
Exhibit 4.1 to Cendant Corporation's Annual Report on Form
10-K filed by Cendant Corporation on March 29, 2001 for the
yearly period ended December 31, 2000).
4.2 Registration Rights Agreement, dated as of April 17, 2002,
by and among AP RES LLC and Cendant Corporation.*
5.1 Opinion of Eric J. Bock, Esq.*
10.1 Stock Purchase Agreement, dated as of April 17, 2002, by
and among Apollo Investment Fund III, L.P., Apollo Overseas
Partners III, L.P., Apollo (UK) Partners III, L.P., AP RES
LLC, Cendant Corporation and Cendant Real Estate Holdings
Inc.*
23.1 Consent of Deloitte & Touche LLP relating to the financial
statements of Cendant Corporation.*
23.2 Consent of KPMG LLP relating to the financial statements of
Galileo International, Inc.*
23.3 Consent of Eric J. Bock, Esq. (included in Exhibit 5.1).*
24.1 Power of Attorney (included on signature page of the
Registration Statement).*
- --------------------
*Previously filed.
Item 17. Undertakings
The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this Registration Statement:
(a) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933, as amended;
(b) To reflect in the prospectus any facts or events arising after
the effective date of the Registration Statement (or the most
recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information
set forth in the Registration Statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not
exceed that which was registered) and any deviation from the low
or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Securities and
Exchange Commission pursuant to Rule 424(b) if, in the aggregate,
the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective
Registration Statement; and
(c) To include any material information with respect to the plan
of distribution not previously disclosed in the Registration
Statement or any material change to such information in the
Registration Statement;
provided, however, that paragraphs (1)(a) and (1)(b) shall not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the
Securities and Exchange Commission by the Registrant pursuant to Section 13
or Section 15(d) of the Securities Exchange Act of 1934 that are
incorporated by reference in the Registration Statement.
(2) That, for the purpose of determining any liability under
the Securities Act of 1933, as amended, each such post-effective amendment
shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the
termination of the offering.
The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, as amended,
each filing of the Registrant's annual report pursuant to Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan's annual report
pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is
incorporated by reference in the Registration Statement shall be deemed to
be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the
Securities Act of 1933, as amended, may be permitted to directors, officers
and controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in the
opinion of the Commission such indemnification is against public policy as
expressed in the Securities Act of 1933, as amended, and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in
the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the
securities being registered, the Registrant will, unless in the opinion of
its counsel the matter has been settled by controlling precedent, submit to
a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the
Securities Act of 1933, as amended, and will be governed by the final
adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933,
Cendant Corporation has duly caused this Amendment No. 1 to the
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of New York, State of New York, on
the 7th day of May, 2002.
CENDANT CORPORATION
By: /s/ James E. Buckman
----------------------------------------
Name: James E. Buckman
Title: Vice Chairman and General Counsel
Pursuant to the requirements of the Securities Act of 1933, this
Amendment No. 1 to the Registration Statement has been signed below by the
following persons in the capacities indicated on May 7, 2002.
Signature Title
--------- -----
* Chairman of the Board of Directors,
- ------------------------------------------
Henry R. Silverman President, Chief Executive Officer and Director
/s/ James E. Buckman Vice Chairman, General Counsel and Director
- ------------------------------------------
James E. Buckman
* Vice Chairman and Director
- ------------------------------------------
Stephen P. Holmes
* Senior Executive Vice President and Chief
- ------------------------------------------
Kevin M. Sheehan Financial Officer (Principal Financial
Officer)
* Executive Vice President, Finance and Chief
- ------------------------------------------
Tobia Ippolito Accounting Officer (Principal Accounting Officer)
* Director
- ------------------------------------------
Myra J. Biblowit
* Director
- ------------------------------------------
Dr. John C. Malone
* Director
- ------------------------------------------
Cheryl D. Mills
* Director
- ------------------------------------------
Leonard S. Coleman
* Director
- ------------------------------------------
Martin L. Edelman
* Director
- ------------------------------------------
Sheli Z. Rosenberg
Director
- ------------------------------------------
The Rt. Hon. Brian Mulroney, P.C., C.C.,
LL.D.
* Director
- ------------------------------------------
Robert W. Pittman
* Director
- ------------------------------------------
Robert F. Smith
* Director
- ------------------------------------------
Robert E. Nederlander
Director
The Honorable William S. Cohen
By: /s/ Eric J. Bock
---------------------------
Eric J. Bock
Attorney-in-Fact
EXHIBIT INDEX
Exhibit
Number Description of Exhibits
- ------ -----------------------
3.1 Amended and Restated Certificate of Incorporation of
Cendant Corporation (incorporated by reference to Exhibit
3.1 to Cendant Corporation's Quarterly Report on Form
10-Q/A filed by Cendant Corporation on July 28, 2000 for
the quarterly period ended March 31, 2000).
3.2 Amended and Restated By-Laws of Cendant Corporation
(incorporated by reference to Exhibit 3.2 to Cendant
Corporation's Quarterly Report on Form 10-Q/A filed by
Cendant Corporation on July 28, 2000 for the quarterly
period ended March 31, 2000).
4.1 Form of Stock Certificate (incorporated by reference to
Exhibit 4.1 to Cendant Corporation's Annual Report on Form
10-K filed by Cendant Corporation on March 29, 2001 for the
yearly period ended December 31, 2000).
4.2 Registration Rights Agreement, dated as of April 17, 2002,
by and among AP RES LLC and Cendant Corporation.*
5.1 Opinion of Eric J. Bock, Esq.*
10.1 Stock Purchase Agreement, dated as of April 17, 2002, by
and among Apollo Investment Fund III, L.P., Apollo Overseas
Partners III, L.P., Apollo (UK) Partners III, L.P., AP RES
LLC, Cendant Corporation and Cendant Real Estate Holdings
Inc.*
23.1 Consent of Deloitte & Touche LLP relating to the financial
statements of Cendant Corporation.*
23.2 Consent of KPMG LLP relating to the financial statements of
Galileo International, Inc.*
23.3 Consent of Eric J. Bock, Esq. (included in Exhibit 5.1).*
24.1 Power of Attorney (included on signature page of the
Registration Statement).*
- --------------------
*Previously filed.